ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
Dow Jones
42.392,27
-0,36%
Euro vs US Dollar
1,02725
0,05%
Bitcoin
96.833,45
-0,07%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

AZTR

Azitra (AZTR)

Azitra Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:AZTR
DatumZeitQuelleÜberschriftSymbolFirma
26/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
12/11/202423h05PR Newswire (US)Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
12/11/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
29/10/202414h00Business WireAzitra to Present at BIO-Europe 2024AMEX:AZTRAzitra Inc
11/10/202415h00Business WireAzitra to Participate in the 2024 Maxim Healthcare Virtual SummitAMEX:AZTRAzitra Inc
09/10/202423h01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:AZTRAzitra Inc
09/10/202422h55Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
24/09/202414h00Business WireAzitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology CongressAMEX:AZTRAzitra Inc
18/09/202415h00Business WireAzitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
16/09/202423h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:AZTRAzitra Inc
06/09/202422h30Business WireAzitra to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:AZTRAzitra Inc
28/08/202414h30Business WireAzitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
22/08/202415h00Business WireAzitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
20/08/202422h15Business WireAzitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
13/08/202400h23Business WireAzitra, Inc. Announces Q2 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
12/08/202423h15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
12/08/202423h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
02/08/202422h05Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:AZTRAzitra Inc
29/07/202422h01Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AZTRAzitra Inc
26/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
25/07/202423h57Business WireCORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public OfferingAMEX:AZTRAzitra Inc
25/07/202420h15Business WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
25/07/202412h03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
24/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AZTRAzitra Inc
24/07/202403h20Business WireAzitra, Inc. Announces Pricing of $10.0 Million Public OfferingAMEX:AZTRAzitra Inc
23/07/202414h00Business WireAzitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed PatentsAMEX:AZTRAzitra Inc
19/07/202423h27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:AZTRAzitra Inc
15/07/202423h11Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AZTRAzitra Inc
15/07/202412h21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AZTRAzitra Inc
09/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

Kürzlich von Ihnen besucht

BOV
PSSA3
PORTO SEGURO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten